Endpoint considerations for clinical trials.
Walton
Marc K
MK
Division of Clinical Trial Design and Analysis, Center for Biologics Evaluation and Research, FDA, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D015203:Reproducibility of Results; D012107:Research Design; D009626:Terminology as Topic; D016896:Treatment Outcome